UnitedHealth Group Key Executives
This section highlights UnitedHealth Group's key executives, including their titles and compensation details.
Find Contacts at UnitedHealth Group
( total contacts)
UnitedHealth Group Earnings
This section highlights UnitedHealth Group's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q1 | 2025 | 2025-04-17 | $7.29 | $7.20 |
| Read Transcript | Q4 | 2024 | 2025-01-16 | $6.74 | $6.81 |
| Read Transcript | Q3 | 2024 | 2024-10-15 | $7.00 | $7.15 |
| Read Transcript | Q2 | 2024 | 2024-07-16 | $6.65 | $6.80 |
| Read Transcript | Q1 | 2024 | 2024-04-16 | $6.61 | $6.91 |
| Read Transcript | Q4 | 2023 | 2024-01-12 | $5.98 | $6.16 |
| Read Transcript | Q3 | 2023 | 2023-10-13 | $6.32 | $6.56 |
| Read Transcript | Q2 | 2023 | 2023-07-14 | $5.99 | $6.14 |
| Read Transcript | Q1 | 2023 | 2023-04-14 | $6.13 | $6.26 |
Financial Statements
Access annual & quarterly financial statements for UnitedHealth Group, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $400.28B | $367.53B | $322.13B | $285.27B | $255.64B |
| Cost of Revenue | $310.88B | $280.66B | $244.54B | $217.94B | $190.14B |
| Gross Profit | $89.40B | $86.87B | $77.59B | $67.33B | $65.50B |
| Gross Profit Ratio | 22.33% | 23.64% | 24.09% | 23.60% | 25.62% |
| Research and Development Expenses | $- | $- | $- | $- | $- |
| General and Administrative Expenses | $- | $- | $- | $- | $- |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $57.11B | $54.63B | $- | $- | $- |
| Other Expenses | $- | $-117.00M | $3.40B | $3.10B | $2.89B |
| Operating Expenses | $57.11B | $54.51B | $51.18B | $45.68B | $44.59B |
| Cost and Expenses | $367.99B | $339.26B | $295.73B | $263.63B | $234.74B |
| Interest Income | $- | $- | $- | $- | $- |
| Interest Expense | $-3.91B | $3.25B | $2.09B | $1.66B | $1.66B |
| Depreciation and Amortization | $4.10B | $3.97B | $3.40B | $3.10B | $2.89B |
| EBITDA | $9.77B | $32.52B | $31.84B | $27.07B | $25.30B |
| EBITDA Ratio | 2.44% | 8.85% | 9.88% | 9.49% | 9.90% |
| Operating Income | $32.29B | $32.36B | $28.43B | $23.97B | $22.41B |
| Operating Income Ratio | 8.07% | 8.80% | 8.83% | 8.40% | 8.76% |
| Total Other Income Expenses Net | $-12.22B | $-3.25B | $-2.09B | $-1.66B | $-1.66B |
| Income Before Tax | $20.07B | $29.11B | $26.34B | $22.31B | $20.74B |
| Income Before Tax Ratio | 5.01% | 7.92% | 8.18% | 7.82% | 8.11% |
| Income Tax Expense | $4.83B | $5.97B | $5.70B | $4.58B | $4.97B |
| Net Income | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B |
| Net Income Ratio | 3.60% | 6.09% | 6.25% | 6.06% | 6.03% |
| EPS | $15.51 | $24.12 | $21.54 | $18.33 | $16.28 |
| EPS Diluted | $15.51 | $23.86 | $21.18 | $18.08 | $16.03 |
| Weighted Average Shares Outstanding | 929.00M | 928.00M | 934.00M | 943.00M | 946.00M |
| Weighted Average Shares Outstanding Diluted | 929.00M | 938.00M | 950.00M | 956.00M | 961.00M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | March 31, 2025 | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $109.58B | $100.81B | $99.18B | $97.86B | $98.78B | $93.25B | $91.36B | $91.79B | $91.93B | $82.79B | $80.89B | $80.33B | $80.15B | $73.74B | $72.34B | $71.32B | $70.20B | $65.47B | $65.11B | $62.14B |
| Cost of Revenue | $85.80B | $79.50B | $77.79B | $76.80B | $76.79B | $72.42B | $68.97B | $70.02B | $69.25B | $61.91B | $60.94B | $60.69B | $61.01B | $56.16B | $55.10B | $54.21B | $52.48B | $49.70B | $49.57B | $42.18B |
| Gross Profit | $23.77B | $21.31B | $21.39B | $21.06B | $21.99B | $20.82B | $22.39B | $21.77B | $22.68B | $20.88B | $19.95B | $19.64B | $19.14B | $17.58B | $17.23B | $17.11B | $17.72B | $15.76B | $15.54B | $19.96B |
| Gross Profit Ratio | 21.70% | 21.14% | 21.56% | 21.52% | 22.26% | 22.33% | 24.51% | 23.72% | 24.67% | 25.22% | 24.67% | 24.45% | 23.88% | 23.84% | 23.82% | 24.00% | 25.24% | 24.08% | 23.87% | 32.12% |
| Research and Development Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| General and Administrative Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $14.65B | $13.54B | $12.68B | $13.19B | $14.06B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Expenses | $- | $- | $- | $- | $- | $974.00M | $14.86B | $1.02B | $14.60B | $982.00M | $828.00M | $802.00M | $788.00M | $771.00M | $796.00M | $778.00M | $758.00M | $732.00M | $719.00M | $717.00M |
| Operating Expenses | $14.65B | $13.54B | $12.68B | $13.19B | $14.06B | $14.31B | $14.86B | $14.83B | $14.60B | $13.99B | $12.49B | $12.51B | $12.19B | $12.04B | $11.52B | $11.14B | $10.98B | $12.25B | $10.89B | $10.72B |
| Cost and Expenses | $100.46B | $93.03B | $90.47B | $89.98B | $90.85B | $86.74B | $83.83B | $84.85B | $83.84B | $75.90B | $73.43B | $73.20B | $73.20B | $68.20B | $66.62B | $65.34B | $63.46B | $61.95B | $60.46B | $52.90B |
| Interest Income | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Interest Expense | $- | $-1.00B | $1.07B | $985.00M | $844.00M | $830.00M | $834.00M | $828.00M | $754.00M | $676.00M | $516.00M | $467.00M | $433.00M | $431.00M | $422.00M | $410.00M | $397.00M | $401.00M | $395.00M | $430.00M |
| Depreciation and Amortization | $1.06B | $1.04B | $1.04B | $1.02B | $997.00M | $974.00M | $1.01B | $1.02B | $970.00M | $982.00M | $828.00M | $802.00M | $788.00M | $771.00M | $796.00M | $778.00M | $758.00M | $732.00M | $719.00M | $717.00M |
| EBITDA | $9.10B | $4.57B | $9.73B | $7.67B | $1.84B | $7.48B | $8.54B | $9.08B | $9.06B | $7.87B | $8.29B | $7.93B | $7.74B | $6.31B | $6.51B | $6.76B | $7.50B | $4.25B | $5.37B | $9.96B |
| EBITDA Ratio | 8.31% | 4.54% | 9.81% | 7.84% | 1.86% | 8.03% | 9.34% | 9.89% | 9.85% | 9.51% | 10.25% | 9.88% | 9.65% | 8.56% | 9.00% | 9.47% | 10.68% | 6.49% | 8.25% | 16.03% |
| Operating Income | $9.12B | $7.77B | $8.71B | $7.88B | $7.93B | $7.69B | $8.53B | $8.06B | $8.09B | $6.89B | $7.46B | $7.13B | $6.95B | $5.54B | $5.71B | $5.98B | $6.74B | $3.52B | $4.65B | $9.24B |
| Operating Income Ratio | 8.32% | 7.71% | 8.78% | 8.05% | 8.03% | 8.25% | 9.33% | 8.78% | 8.80% | 8.32% | 9.22% | 8.88% | 8.67% | 7.51% | 7.90% | 8.38% | 9.60% | 5.37% | 7.14% | 14.87% |
| Total Other Income Expenses Net | $-1.01B | $-982.00M | $-1.09B | $-2.21B | $-7.93B | $-830.00M | $-834.00M | $-828.00M | $-754.00M | $-676.00M | $-516.00M | $-467.00M | $-433.00M | $-431.00M | $-422.00M | $-410.00M | $-397.00M | $-401.00M | $-395.00M | $-430.00M |
| Income Before Tax | $8.11B | $6.79B | $7.61B | $5.67B | $1.00M | $6.86B | $7.69B | $7.23B | $7.33B | $6.21B | $6.95B | $6.67B | $6.52B | $5.11B | $5.29B | $5.57B | $6.34B | $3.12B | $4.26B | $8.81B |
| Income Before Tax Ratio | 7.40% | 6.74% | 7.68% | 5.79% | 0.00% | 7.36% | 8.42% | 7.88% | 7.98% | 7.51% | 8.59% | 8.30% | 8.13% | 6.93% | 7.31% | 7.81% | 9.03% | 4.76% | 6.54% | 14.18% |
| Income Tax Expense | $1.63B | $1.01B | $1.36B | $1.24B | $1.22B | $1.18B | $1.65B | $1.57B | $1.56B | $1.31B | $1.56B | $1.47B | $1.37B | $919.00M | $1.10B | $1.20B | $1.36B | $764.00M | $1.00B | $2.12B |
| Net Income | $6.29B | $5.54B | $6.05B | $4.22B | $-1.41B | $5.46B | $5.84B | $5.47B | $5.61B | $4.76B | $5.26B | $5.07B | $5.03B | $4.07B | $4.09B | $4.27B | $4.86B | $2.21B | $3.17B | $6.64B |
| Net Income Ratio | 5.74% | 5.50% | 6.11% | 4.31% | -1.43% | 5.85% | 6.39% | 5.96% | 6.10% | 5.75% | 6.50% | 6.31% | 6.27% | 5.52% | 5.65% | 5.98% | 6.93% | 3.38% | 4.87% | 10.68% |
| EPS | $7.20 | $5.98 | $6.56 | $4.58 | $-1.53 | $5.90 | $6.31 | $5.89 | $6.02 | $5.10 | $5.63 | $5.42 | $5.35 | $4.33 | $4.34 | $4.52 | $5.15 | $2.34 | $3.34 | $6.99 |
| EPS Diluted | $6.85 | $5.98 | $6.51 | $4.54 | $-1.53 | $5.83 | $6.24 | $5.82 | $5.95 | $5.03 | $5.55 | $5.34 | $5.27 | $4.26 | $4.28 | $4.46 | $5.08 | $2.30 | $3.30 | $6.91 |
| Weighted Average Shares Outstanding | 918.00M | 927.00M | 923.00M | 921.00M | 920.00M | 924.00M | 926.00M | 930.00M | 932.00M | 934.00M | 935.00M | 935.00M | 939.00M | 941.00M | 942.00M | 943.00M | 944.00M | 946.00M | 949.00M | 950.00M |
| Weighted Average Shares Outstanding Diluted | 918.00M | 927.00M | 930.00M | 928.00M | 922.00M | 935.00M | 936.00M | 940.00M | 943.00M | 947.00M | 948.00M | 950.00M | 954.00M | 955.00M | 955.00M | 956.00M | 957.00M | 961.00M | 962.00M | 960.00M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $25.31B | $25.43B | $23.36B | $21.38B | $16.92B |
| Short Term Investments | $3.80B | $4.20B | $4.55B | $2.53B | $2.86B |
| Cash and Short Term Investments | $29.11B | $29.63B | $27.91B | $23.91B | $19.78B |
| Net Receivables | $48.45B | $38.97B | $30.45B | $28.08B | $25.40B |
| Inventory | $- | $- | $- | $- | $- |
| Other Current Assets | $8.21B | $9.84B | $10.71B | $9.77B | $8.53B |
| Total Current Assets | $85.78B | $78.44B | $69.07B | $61.76B | $53.72B |
| Property Plant Equipment Net | $10.55B | $11.45B | $10.13B | $8.97B | $8.63B |
| Goodwill | $106.73B | $103.73B | $93.35B | $75.80B | $71.34B |
| Intangible Assets | $23.27B | $15.19B | $14.40B | $10.04B | $10.86B |
| Goodwill and Intangible Assets | $130.00B | $118.93B | $107.75B | $85.84B | $82.19B |
| Long Term Investments | $52.35B | $- | $43.73B | $43.11B | $41.24B |
| Tax Assets | $- | $- | $2.77B | $-94.81B | $-90.82B |
| Other Non-Current Assets | $19.59B | $64.91B | $12.26B | $107.33B | $102.33B |
| Total Non-Current Assets | $212.50B | $195.28B | $176.64B | $150.45B | $143.57B |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B |
| Account Payables | $68.56B | $31.96B | $56.77B | $49.13B | $44.37B |
| Short Term Debt | $4.54B | $4.27B | $3.11B | $3.62B | $4.82B |
| Tax Payables | $- | $- | $- | $- | $- |
| Deferred Revenue | $3.32B | $3.35B | $3.08B | $2.57B | $2.84B |
| Other Current Liabilities | $27.35B | $59.47B | $26.28B | $22.98B | $20.39B |
| Total Current Liabilities | $103.77B | $99.05B | $89.24B | $78.29B | $72.42B |
| Long Term Debt | $72.36B | $62.12B | $54.51B | $42.38B | $38.65B |
| Deferred Revenue Non-Current | $- | $3.35B | $2.77B | $-3.27B | $-3.37B |
| Deferred Tax Liabilities Non-Current | $3.62B | $3.02B | $2.77B | $3.27B | $3.37B |
| Other Non-Current Liabilities | $15.94B | $11.94B | $15.61B | $15.05B | $15.68B |
| Total Non-Current Liabilities | $91.92B | $80.44B | $70.12B | $57.44B | $54.33B |
| Other Liabilities | $- | $-4.70B | $- | $- | $- |
| Total Liabilities | $195.69B | $174.80B | $159.36B | $135.73B | $126.75B |
| Preferred Stock | $- | $- | $- | $- | $- |
| Common Stock | $9.00M | $9.00M | $9.00M | $10.00M | $10.00M |
| Retained Earnings | $96.04B | $95.77B | $86.16B | $77.13B | $69.30B |
| Accumulated Other Comprehensive Income Loss | $-3.39B | $-7.03B | $-8.39B | $-5.38B | $-3.81B |
| Other Total Stockholders Equity | $- | $- | $- | $- | $- |
| Total Stockholders Equity | $92.66B | $88.76B | $77.77B | $71.76B | $65.49B |
| Total Equity | $102.59B | $98.92B | $86.35B | $76.48B | $70.54B |
| Total Liabilities and Stockholders Equity | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B |
| Minority Interest | $9.93B | $10.16B | $8.57B | $4.72B | $5.05B |
| Total Liabilities and Total Equity | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B |
| Total Investments | $56.16B | $4.20B | $71.64B | $45.65B | $44.10B |
| Total Debt | $76.90B | $62.54B | $57.62B | $46.00B | $43.47B |
| Net Debt | $51.59B | $37.11B | $34.26B | $24.63B | $26.55B |
Balance Sheet Charts
| Breakdown | March 31, 2025 | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $34.29B | $25.31B | $32.40B | $26.29B | $28.41B | $25.43B | $38.91B | $46.28B | $41.91B | $23.36B | $38.84B | $24.61B | $25.48B | $21.38B | $21.09B | $19.83B | $19.95B | $16.92B | $17.55B | $22.33B |
| Short Term Investments | $- | $3.80B | $4.73B | $5.04B | $4.30B | $4.20B | $5.18B | $46.28B | $4.58B | $4.55B | $3.68B | $3.35B | $2.91B | $2.53B | $2.79B | $2.73B | $2.96B | $2.86B | $3.26B | $3.27B |
| Cash and Short Term Investments | $34.29B | $29.11B | $37.13B | $31.32B | $32.71B | $29.63B | $44.10B | $46.28B | $46.50B | $27.91B | $42.53B | $27.96B | $28.40B | $23.91B | $23.87B | $22.56B | $22.92B | $19.78B | $20.81B | $25.59B |
| Net Receivables | $26.94B | $48.45B | $47.48B | $49.88B | $46.48B | $38.97B | $38.42B | $34.08B | $37.11B | $17.68B | $30.73B | $31.16B | $30.86B | $14.22B | $28.23B | $27.22B | $27.53B | $12.87B | $25.40B | $23.98B |
| Inventory | $- | $- | $- | $- | $-74.89B | $-68.60B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Current Assets | $35.06B | $8.21B | $7.64B | $10.84B | $9.75B | $9.84B | $9.38B | $9.51B | $10.29B | $23.48B | $9.68B | $9.23B | $9.77B | $23.64B | $9.51B | $9.14B | $9.06B | $21.07B | $8.61B | $9.35B |
| Total Current Assets | $96.28B | $85.78B | $92.26B | $92.04B | $88.94B | $78.44B | $91.91B | $89.87B | $93.89B | $69.07B | $82.94B | $68.36B | $69.03B | $61.76B | $61.61B | $58.92B | $59.51B | $53.72B | $54.82B | $58.92B |
| Property Plant Equipment Net | $- | $10.55B | $10.14B | $9.80B | $10.43B | $11.45B | $11.07B | $10.93B | $10.64B | $10.13B | $9.47B | $9.42B | $9.18B | $8.97B | $8.73B | $8.73B | $8.50B | $8.63B | $8.15B | $8.13B |
| Goodwill | $- | $106.73B | $105.98B | $105.44B | $105.66B | $103.73B | $101.70B | $101.67B | $100.41B | $93.35B | $83.90B | $84.16B | $77.55B | $75.80B | $75.44B | $75.83B | $72.16B | $71.34B | $68.09B | $67.87B |
| Intangible Assets | $- | $23.27B | $23.59B | $14.73B | $15.54B | $15.19B | $15.20B | $15.64B | $16.16B | $14.40B | $10.79B | $11.29B | $9.92B | $10.04B | $10.44B | $10.81B | $10.84B | $10.86B | $10.37B | $10.55B |
| Goodwill and Intangible Assets | $- | $130.00B | $129.57B | $120.17B | $121.21B | $118.93B | $116.90B | $117.31B | $116.57B | $107.75B | $94.69B | $95.44B | $87.47B | $85.84B | $85.87B | $86.63B | $83.00B | $82.19B | $78.46B | $78.42B |
| Long Term Investments | $51.86B | $52.35B | $48.69B | $46.11B | $5.50B | $47.61B | $45.47B | $45.99B | $46.88B | $43.73B | $41.56B | $42.43B | $42.35B | $43.11B | $44.78B | $44.06B | $42.41B | $41.24B | $39.18B | $36.78B |
| Tax Assets | $- | $- | $4.01B | $3.63B | $4.17B | $4.70B | $2.21B | $2.50B | $- | $4.60B | $1.66B | $2.58B | $2.95B | $-94.81B | $3.65B | $3.64B | $3.60B | $-90.82B | $3.34B | $3.29B |
| Other Non-Current Assets | $161.64B | $19.59B | $18.65B | $14.31B | $53.96B | $17.30B | $14.50B | $13.57B | $15.69B | $10.43B | $12.75B | $11.94B | $10.25B | $107.33B | $8.41B | $8.31B | $8.15B | $102.33B | $7.01B | $6.95B |
| Total Non-Current Assets | $213.50B | $212.50B | $207.05B | $194.02B | $195.27B | $199.98B | $190.16B | $190.29B | $189.78B | $176.64B | $160.13B | $161.82B | $152.21B | $150.45B | $151.44B | $151.38B | $145.66B | $143.57B | $136.15B | $133.56B |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $309.79B | $298.28B | $299.31B | $286.06B | $284.21B | $278.42B | $282.06B | $280.16B | $283.68B | $245.71B | $243.06B | $230.17B | $221.24B | $212.21B | $213.04B | $210.29B | $205.17B | $197.29B | $190.97B | $192.48B |
| Account Payables | $- | $68.56B | $- | $63.43B | $64.77B | $31.96B | $63.96B | $61.46B | $61.66B | $56.77B | $56.30B | $54.12B | $53.73B | $49.13B | $24.29B | $23.01B | $47.83B | $44.37B | $42.34B | $44.62B |
| Short Term Debt | $9.99B | $4.54B | $3.91B | $11.37B | $9.79B | $5.31B | $5.29B | $6.32B | $9.93B | $3.11B | $3.23B | $5.59B | $6.70B | $3.62B | $3.62B | $3.87B | $8.84B | $4.82B | $3.90B | $6.16B |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $3.32B | $3.32B | $2.57B | $3.21B | $3.35B | $15.31B | $14.85B | $14.49B | $3.08B | $12.85B | $2.21B | $2.67B | $2.57B | $2.56B | $2.37B | $2.61B | $2.84B | $2.39B | $2.30B |
| Other Current Liabilities | $103.48B | $27.35B | $94.34B | $27.29B | $26.67B | $58.43B | $29.62B | $30.34B | $30.40B | $26.28B | $28.56B | $26.77B | $25.06B | $22.98B | $49.11B | $47.31B | $21.36B | $20.39B | $17.97B | $16.80B |
| Total Current Liabilities | $113.47B | $103.77B | $101.56B | $104.67B | $104.43B | $99.05B | $114.18B | $112.98B | $116.48B | $89.24B | $100.94B | $88.70B | $88.17B | $78.29B | $79.58B | $76.56B | $80.64B | $72.42B | $66.60B | $69.88B |
| Long Term Debt | $- | $72.36B | $74.10B | $63.73B | $63.85B | $62.12B | $58.08B | $59.27B | $60.66B | $58.35B | $45.44B | $45.80B | $40.80B | $45.79B | $43.34B | $44.35B | $37.42B | $43.09B | $39.90B | $39.90B |
| Deferred Revenue Non-Current | $- | $- | $- | $-18.43B | $3.21B | $3.35B | $-2.21B | $-2.50B | $- | $2.77B | $1.66B | $2.21B | $2.67B | $3.27B | $-3.65B | $-3.64B | $-3.60B | $3.37B | $-3.34B | $-3.29B |
| Deferred Tax Liabilities Non-Current | $- | $3.62B | $- | $3.63B | $4.17B | $7.72B | $2.21B | $2.50B | $2.83B | $2.77B | $1.66B | $2.58B | $2.95B | $3.27B | $3.65B | $3.64B | $3.60B | $3.37B | $3.34B | $3.29B |
| Other Non-Current Liabilities | $- | $15.94B | $19.19B | $14.79B | $14.84B | $11.94B | $13.62B | $13.26B | $13.08B | $8.70B | $12.11B | $11.97B | $11.67B | $9.08B | $11.84B | $12.43B | $12.93B | $8.39B | $11.19B | $11.06B |
| Total Non-Current Liabilities | $- | $91.92B | $93.29B | $63.73B | $82.86B | $80.44B | $73.90B | $75.03B | $76.58B | $70.12B | $59.21B | $60.35B | $55.42B | $57.44B | $58.84B | $60.41B | $53.95B | $54.33B | $54.42B | $54.24B |
| Other Liabilities | $- | $- | $- | $18.43B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $- | $195.69B | $194.85B | $186.82B | $187.29B | $179.50B | $188.08B | $188.01B | $193.06B | $159.36B | $160.14B | $149.04B | $143.59B | $135.73B | $138.41B | $136.97B | $134.59B | $126.75B | $121.02B | $124.13B |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $- | $9.00M | $9.00M | $9.00M | $9.00M | $9.00M | $9.00M | $9.00M | $9.00M | $9.00M | $10.00M | $10.00M | $10.00M | $10.00M | $10.00M | $10.00M | $10.00M | $10.00M | $10.00M | $10.00M |
| Retained Earnings | $- | $96.04B | $96.52B | $92.40B | $90.12B | $95.77B | $93.17B | $89.99B | $88.85B | $86.16B | $83.72B | $80.54B | $78.78B | $77.13B | $75.12B | $73.09B | $71.22B | $69.30B | $69.72B | $67.78B |
| Accumulated Other Comprehensive Income Loss | $- | $-3.39B | $-2.45B | $-3.42B | $-3.44B | $-7.03B | $-8.69B | $-7.65B | $-7.55B | $-8.39B | $-9.09B | $-7.73B | $-6.03B | $-5.38B | $-4.86B | $-4.09B | $-4.83B | $-3.81B | $-4.49B | $-4.55B |
| Other Total Stockholders Equity | $- | $- | $5.81B | $373.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $388.00M |
| Total Stockholders Equity | $- | $92.66B | $99.88B | $84.80B | $86.69B | $88.76B | $84.49B | $82.35B | $81.31B | $77.77B | $74.65B | $72.82B | $72.77B | $71.76B | $70.28B | $69.01B | $66.40B | $65.49B | $65.23B | $63.62B |
| Total Equity | $4.36B | $102.59B | $104.45B | $94.68B | $96.92B | $98.92B | $93.98B | $92.16B | $90.62B | $86.35B | $82.92B | $81.13B | $77.65B | $76.48B | $74.63B | $73.32B | $70.58B | $70.54B | $69.95B | $68.36B |
| Total Liabilities and Stockholders Equity | $309.79B | $298.28B | $299.31B | $286.06B | $284.21B | $273.72B | $282.06B | $280.16B | $283.68B | $245.71B | $243.06B | $230.17B | $221.24B | $212.21B | $213.04B | $210.29B | $205.17B | $197.29B | $190.97B | $192.48B |
| Minority Interest | $4.36B | $9.93B | $4.57B | $9.88B | $10.23B | $10.16B | $9.49B | $9.80B | $9.31B | $8.57B | $8.28B | $8.31B | $4.88B | $4.72B | $4.35B | $4.31B | $4.18B | $5.05B | $4.72B | $4.73B |
| Total Liabilities and Total Equity | $309.79B | $298.28B | $299.31B | $286.06B | $284.21B | $273.72B | $282.06B | $280.16B | $283.68B | $245.71B | $243.06B | $230.17B | $221.24B | $212.21B | $213.04B | $210.29B | $205.17B | $197.29B | $190.97B | $192.48B |
| Total Investments | $51.86B | $56.16B | $53.42B | $51.15B | $9.80B | $4.20B | $45.47B | $45.99B | $51.47B | $71.64B | $45.24B | $45.78B | $45.27B | $45.65B | $47.56B | $46.79B | $45.37B | $44.10B | $42.44B | $40.04B |
| Total Debt | $9.99B | $76.90B | $78.01B | $75.10B | $73.64B | $67.44B | $63.37B | $65.59B | $70.59B | $57.62B | $48.67B | $51.39B | $47.49B | $46.00B | $46.97B | $48.22B | $46.26B | $43.47B | $43.79B | $46.06B |
| Net Debt | $-24.30B | $51.59B | $45.61B | $48.81B | $45.22B | $42.01B | $24.45B | $19.31B | $28.68B | $34.26B | $9.82B | $26.78B | $22.01B | $24.63B | $25.88B | $28.38B | $26.30B | $26.55B | $26.24B | $23.73B |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $15.24B | $22.38B | $20.64B | $17.73B | $15.77B |
| Depreciation and Amortization | $4.10B | $3.97B | $3.40B | $3.10B | $2.89B |
| Deferred Income Tax | $-296.00M | $-245.00M | $-1.00B | $-814.00M | $-60.00M |
| Stock Based Compensation | $1.02B | $1.06B | $925.00M | $800.00M | $679.00M |
| Change in Working Capital | $-808.00M | $1.64B | $2.25B | $1.52B | $2.90B |
| Accounts Receivables | $- | $-3.11B | $-2.52B | $-1.00B | $-688.00M |
| Inventory | $- | $1.04B | $- | $-1.03B | $-2.19B |
| Accounts Payables | $- | $3.52B | $1.96B | $3.86B | $5.50B |
| Other Working Capital | $-808.00M | $203.00M | $2.81B | $-310.00M | $278.00M |
| Other Non Cash Items | $4.95B | $258.00M | $7.24B | $6.64B | $6.77B |
| Net Cash Provided by Operating Activities | $24.20B | $29.07B | $26.21B | $22.34B | $22.17B |
| Investments in Property Plant and Equipment | $-3.50B | $-3.39B | $-2.80B | $-2.45B | $-2.05B |
| Acquisitions Net | $-13.41B | $-10.14B | $-21.46B | $-4.82B | $-7.14B |
| Purchases of Investments | $-27.31B | $-18.31B | $-6.84B | $-1.84B | $-2.84B |
| Sales Maturities of Investments | $27.83B | $16.54B | $11.99B | $15.30B | $13.74B |
| Other Investing Activities | $-4.14B | $-275.00M | $-9.37B | $-16.55B | $-14.25B |
| Net Cash Used for Investing Activities | $-20.53B | $-15.57B | $-28.48B | $-10.37B | $-12.53B |
| Debt Repayment | $14.66B | $4.28B | $12.54B | $2.48B | $1.71B |
| Common Stock Issued | $1.85B | $1.35B | $1.25B | $1.35B | $1.44B |
| Common Stock Repurchased | $-9.00B | $-8.00B | $-7.00B | $-5.00B | $-4.25B |
| Dividends Paid | $-7.53B | $-6.76B | $-5.99B | $-5.28B | $-4.58B |
| Other Financing Activities | $-3.48B | $-2.40B | $3.43B | $-1.01B | $2.09B |
| Net Cash Used Provided by Financing Activities | $-3.51B | $-11.53B | $4.23B | $-7.46B | $-3.59B |
| Effect of Forex Changes on Cash | $-61.00M | $97.00M | $34.00M | $-62.00M | $-116.00M |
| Net Change in Cash | $-115.00M | $2.06B | $1.99B | $4.45B | $5.94B |
| Cash at End of Period | $25.31B | $25.43B | $23.36B | $21.38B | $16.92B |
| Cash at Beginning of Period | $25.43B | $23.36B | $21.38B | $16.92B | $10.98B |
| Operating Cash Flow | $24.20B | $29.07B | $26.21B | $22.34B | $22.17B |
| Capital Expenditure | $-3.50B | $-3.39B | $-2.80B | $-2.45B | $-2.05B |
| Free Cash Flow | $20.70B | $25.68B | $23.40B | $19.89B | $20.12B |
Cash Flow Charts
| Breakdown | March 31, 2025 | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $6.47B | $5.54B | $6.05B | $4.22B | $-1.41B | $5.46B | $6.04B | $5.66B | $5.77B | $4.91B | $5.38B | $5.20B | $5.15B | $4.19B | $4.19B | $4.37B | $4.98B | $2.35B | $3.26B | $6.70B |
| Depreciation and Amortization | $1.06B | $1.04B | $1.04B | $1.02B | $997.00M | $974.00M | $1.01B | $1.02B | $970.00M | $982.00M | $828.00M | $802.00M | $788.00M | $771.00M | $796.00M | $778.00M | $758.00M | $732.00M | $719.00M | $717.00M |
| Deferred Income Tax | $- | $- | $124.00M | $-331.00M | $-27.00M | $249.00M | $-71.00M | $-241.00M | $-332.00M | $-414.00M | $-790.00M | $-176.00M | $178.00M | $-992.00M | $65.00M | $-173.00M | $286.00M | $-227.00M | $-71.00M | $-9.00M |
| Stock Based Compensation | $375.00M | $187.00M | $237.00M | $222.00M | $372.00M | $208.00M | $247.00M | $242.00M | $362.00M | $250.00M | $171.00M | $205.00M | $299.00M | $209.00M | $165.00M | $170.00M | $256.00M | $152.00M | $139.00M | $157.00M |
| Change in Working Capital | $- | $-740.00M | $7.33B | $-91.00M | $-6.24B | $-11.85B | $-410.00M | $4.42B | $9.48B | $-10.26B | $12.96B | $643.00M | $-1.09B | $-961.00M | $2.36B | $393.00M | $-273.00M | $3.09B | $-916.00M | $2.44B |
| Accounts Receivables | $- | $-685.00M | $3.16B | $3.69B | $-6.16B | $-540.00M | $-2.77B | $4.50B | $-4.31B | $40.00M | $1.64B | $317.00M | $-4.52B | $-153.00M | $371.00M | $1.68B | $-2.90B | $-494.00M | $245.00M | $2.21B |
| Inventory | $- | $- | $- | $- | $- | $-441.00M | $1.07B | $-185.00M | $- | $- | $- | $- | $- | $404.00M | $88.00M | $-568.00M | $-955.00M | $502.00M | $1.09B | $465.00M |
| Accounts Payables | $- | $- | $1.21B | $267.00M | $-231.00M | $1.15B | $823.00M | $-249.00M | $1.80B | $-3.64B | $772.00M | $218.00M | $4.44B | $-1.23B | $1.71B | $-454.00M | $3.84B | $2.67B | $-2.41B | $-19.00M |
| Other Working Capital | $- | $-55.00M | $2.96B | $-563.00M | $9.00M | $-12.02B | $466.00M | $353.00M | $11.99B | $-6.66B | $10.54B | $-518.00M | $-1.01B | $21.00M | $192.00M | $-262.00M | $-261.00M | $410.00M | $164.00M | $-217.00M |
| Other Non Cash Items | $-2.45B | $-3.66B | $-846.00M | $3.64B | $9.79B | $-226.00M | $91.00M | $-69.00M | $69.00M | $1.95B | $1.16B | $198.00M | $2.17B | $879.00M | $1.93B | $1.66B | $-55.00M | $-100.00M | $-76.00M | $79.00M |
| Net Cash Provided by Operating Activities | $5.46B | $2.37B | $13.95B | $6.75B | $1.14B | $-5.19B | $6.90B | $11.03B | $16.33B | $-4.53B | $18.55B | $6.87B | $5.32B | $3.22B | $7.58B | $5.54B | $6.00B | $6.10B | $3.13B | $10.00B |
| Investments in Property Plant and Equipment | $-898.00M | $-912.00M | $-991.00M | $-853.00M | $-743.00M | $-959.00M | $-838.00M | $-829.00M | $-760.00M | $-866.00M | $-724.00M | $-657.00M | $-555.00M | $-695.00M | $-629.00M | $-562.00M | $-568.00M | $-574.00M | $-557.00M | $-451.00M |
| Acquisitions Net | $-702.00M | $-1.73B | $-8.64B | $-25.00M | $-3.01B | $-1.79B | $-228.00M | $-335.00M | $-7.83B | $-14.30B | $-4.00M | $-5.92B | $-1.23B | $-94.00M | $-85.00M | $-3.45B | $-1.19B | $-2.81B | $-374.00M | $-3.02B |
| Purchases of Investments | $1.22B | $-7.36B | $-9.82B | $-5.33B | $-4.80B | $-5.32B | $6.38B | $3.32B | $-4.89B | $-2.77B | $-701.00M | $-3.92B | $-1.63B | $1.86B | $5.14B | $-4.24B | $-4.61B | $-1.45B | $5.03B | $-2.55B |
| Sales Maturities of Investments | $- | $6.03B | $11.89B | $4.62B | $5.29B | $6.39B | $-7.65B | $-2.58B | $2.58B | $1.87B | $4.58B | $2.19B | $3.35B | $6.17B | $3.07B | $3.16B | $2.90B | $3.56B | $3.20B | $543.00M |
| Other Investing Activities | $309.00M | $2.85B | $1.91B | $-5.83B | $-3.08B | $-239.00M | $-297.00M | $-309.00M | $-115.00M | $699.00M | $-4.00B | $-277.00M | $-3.60B | $-6.53B | $-9.38B | $-416.00M | $-232.00M | $-3.90B | $-10.16B | $2.52B |
| Net Cash Used for Investing Activities | $-74.00M | $-1.12B | $-5.65B | $-7.42B | $-6.34B | $-1.92B | $-2.64B | $-728.00M | $-11.02B | $-15.37B | $-847.00M | $-8.59B | $-3.67B | $716.00M | $-1.88B | $-5.50B | $-3.71B | $-5.18B | $-2.87B | $-2.95B |
| Debt Repayment | $- | $-460.00M | $2.33B | $1.43B | $11.36B | $-1.57B | $-1.85B | $-4.68B | $12.38B | $8.73B | $-2.36B | $4.11B | $2.05B | $-1.25B | $-1.12B | $-750.00M | $2.91B | $-355.00M | $-2.27B | $-5.58B |
| Common Stock Issued | $- | $235.00M | $867.00M | $258.00M | $486.00M | $314.00M | $411.00M | $284.00M | $344.00M | $169.00M | $328.00M | $205.00M | $551.00M | $278.00M | $313.00M | $328.00M | $436.00M | $234.00M | $336.00M | $313.00M |
| Common Stock Repurchased | $-3.00B | $-4.97B | $-956.00M | $- | $-3.07B | $-1.50B | $-1.50B | $-3.00B | $-2.00B | $-1.00B | $-1.00B | $-2.50B | $-2.50B | $-1.05B | $-1.05B | $-1.25B | $-1.65B | $-1.71B | $-850.00M | $- |
| Dividends Paid | $-1.91B | $-1.93B | $-1.94B | $-1.94B | $-1.73B | $-1.74B | $-1.74B | $-1.75B | $-1.54B | $-1.54B | $-1.54B | $-1.54B | $-1.36B | $-1.36B | $-1.37B | $-1.37B | $-1.18B | $-1.18B | $-1.19B | $-1.19B |
| Other Financing Activities | $2.01B | $-1.21B | $-2.51B | $-945.00M | $1.18B | $-1.93B | $-2.43B | $-1.32B | $4.01B | $-1.97B | $1.15B | $672.00M | $3.57B | $-238.00M | $-1.17B | $2.82B | $275.00M | $1.42B | $-1.04B | $178.00M |
| Net Cash Used Provided by Financing Activities | $99.00M | $-8.34B | $-2.21B | $-1.20B | $8.23B | $-6.43B | $-7.10B | $-10.46B | $13.19B | $4.39B | $-3.42B | $946.00M | $2.30B | $-3.63B | $-4.40B | $-218.00M | $787.00M | $-1.60B | $-5.02B | $-6.28B |
| Effect of Forex Changes on Cash | $15.00M | $-31.00M | $14.00M | $4.00M | $-48.00M | $48.00M | $-57.00M | $55.00M | $51.00M | $30.00M | $-53.00M | $-100.00M | $157.00M | $-17.00M | $-51.00M | $57.00M | $-51.00M | $44.00M | $-17.00M | $-14.00M |
| Net Change in Cash | $5.41B | $-7.09B | $6.11B | $-2.13B | $2.99B | $-13.49B | $-2.90B | $-100.00M | $18.55B | $-15.48B | $14.23B | $-870.00M | $4.11B | $290.00M | $1.25B | $-123.00M | $3.03B | $-629.00M | $-4.78B | $758.00M |
| Cash at End of Period | $30.72B | $25.31B | $32.40B | $26.29B | $28.41B | $25.43B | $38.91B | $41.81B | $41.91B | $23.36B | $38.84B | $24.61B | $25.48B | $21.38B | $21.09B | $19.83B | $19.95B | $16.92B | $17.55B | $22.33B |
| Cash at Beginning of Period | $25.31B | $32.40B | $26.29B | $28.41B | $25.43B | $38.91B | $41.81B | $41.91B | $23.36B | $38.84B | $24.61B | $25.48B | $21.38B | $21.09B | $19.83B | $19.95B | $16.92B | $17.55B | $22.33B | $21.57B |
| Operating Cash Flow | $5.46B | $2.37B | $13.95B | $6.75B | $1.14B | $-5.19B | $6.90B | $11.03B | $16.33B | $-4.53B | $18.55B | $6.87B | $5.32B | $3.22B | $7.58B | $5.54B | $6.00B | $6.10B | $3.13B | $10.00B |
| Capital Expenditure | $-898.00M | $-912.00M | $-991.00M | $-853.00M | $-743.00M | $-959.00M | $-838.00M | $-829.00M | $-760.00M | $-866.00M | $-724.00M | $-657.00M | $-555.00M | $-695.00M | $-629.00M | $-562.00M | $-568.00M | $-574.00M | $-557.00M | $-451.00M |
| Free Cash Flow | $4.56B | $1.46B | $12.95B | $5.89B | $401.00M | $-6.15B | $6.06B | $10.20B | $15.57B | $-5.40B | $17.82B | $6.21B | $4.76B | $2.52B | $6.95B | $4.98B | $5.44B | $5.53B | $2.57B | $9.55B |
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
$309.72
Stock Price
$280.96B
Market Cap
400.00K
Employees
Minnetonka, MN
Location
Revenue (FY 2024)
$400.28B
8.9% YoY
Net Income (FY 2024)
$14.40B
-35.6% YoY
EPS (FY 2024)
$15.51
-35.0% YoY
Free Cash Flow (FY 2024)
$20.70B
-19.4% YoY
Profitability
Gross Margin
22.3%
Net Margin
3.6%
ROE
15.5%
ROA
4.8%
Valuation
P/E Ratio
32.62
P/S Ratio
1.17
EV/EBITDA
53.39
Market Cap
$280.96B
Revenue & Net Income
Profit Margins
Cash Flow Summary
Operating Cash Flow
$24.20B
-16.7% YoY
Free Cash Flow
$20.70B
-19.4% YoY
Balance Sheet Summary
Total Assets
$298.28B
9.0% YoY
Total Debt
$76.90B
23.0% YoY
Shareholder Equity
$92.66B
3.6% YoY
Dividend Overview
$2.10
Latest Dividend
%
Dividend Yield
%
Payout Ratio
Recent Dividend History
| Date | Amount | Type |
|---|---|---|
| 2025-03-10 | $2.10 | March 10, 25 |
| 2024-12-09 | $2.10 | December 09, 24 |
| 2024-09-16 | $2.10 | September 16, 24 |
| 2024-06-17 | $2.10 | June 17, 24 |
| 2024-03-08 | $1.88 | March 08, 24 |
| 2023-12-01 | $1.88 | December 01, 23 |
| 2023-09-08 | $1.88 | September 08, 23 |
| 2023-06-15 | $1.88 | June 15, 23 |
| 2023-03-10 | $1.65 | March 10, 23 |
| 2022-12-02 | $1.65 | December 02, 22 |
UnitedHealth Group Dividends
Explore UnitedHealth Group's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
1.60%
Dividend Payout Ratio
52.29%
Dividend Paid & Capex Coverage Ratio
2.19x
UnitedHealth Group Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $2.1 | $2.1 | March 10, 2025 | March 10, 2025 | March 18, 2025 | February 24, 2025 |
| $2.1 | $2.1 | December 09, 2024 | December 09, 2024 | December 17, 2024 | November 06, 2024 |
| $2.1 | $2.1 | September 16, 2024 | September 16, 2024 | December 17, 2024 | November 06, 2024 |
| $2.1 | $2.1 | June 17, 2024 | June 17, 2024 | June 25, 2024 | June 05, 2024 |
| $1.88 | $1.88 | March 08, 2024 | March 11, 2024 | March 19, 2024 | February 23, 2024 |
| $1.88 | $1.88 | December 01, 2023 | December 04, 2023 | December 12, 2023 | November 08, 2023 |
| $1.88 | $1.88 | September 08, 2023 | September 11, 2023 | September 19, 2023 | August 23, 2023 |
| $1.88 | $1.88 | June 15, 2023 | June 19, 2023 | June 27, 2023 | June 07, 2023 |
| $1.65 | $1.65 | March 10, 2023 | March 13, 2023 | March 21, 2023 | February 27, 2023 |
| $1.65 | $1.65 | December 02, 2022 | December 05, 2022 | December 13, 2022 | November 04, 2022 |
| $1.65 | $1.65 | September 09, 2022 | September 12, 2022 | September 20, 2022 | August 17, 2022 |
| $1.65 | $1.65 | June 16, 2022 | June 20, 2022 | June 28, 2022 | June 08, 2022 |
| $1.45 | $1.45 | March 11, 2022 | March 14, 2022 | March 22, 2022 | February 16, 2022 |
| $1.45 | $1.45 | December 03, 2021 | December 06, 2021 | December 14, 2021 | November 05, 2021 |
| $1.45 | $1.45 | September 10, 2021 | September 13, 2021 | September 21, 2021 | August 11, 2021 |
| $1.45 | $1.45 | June 18, 2021 | June 21, 2021 | June 29, 2021 | June 09, 2021 |
| $1.25 | $1.25 | March 12, 2021 | March 15, 2021 | March 23, 2021 | February 24, 2021 |
| $1.25 | $1.25 | December 04, 2020 | December 07, 2020 | December 15, 2020 | November 04, 2020 |
| $1.25 | $1.25 | September 11, 2020 | September 14, 2020 | September 22, 2020 | August 05, 2020 |
| $1.25 | $1.25 | June 19, 2020 | June 22, 2020 | June 30, 2020 | June 02, 2020 |
UnitedHealth Group News
Read the latest news about UnitedHealth Group, including recent articles, headlines, and updates.
United Health Group Incorporated Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - UNH
LOS ANGELES , May 19, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of UnitedHealth Group Incorporated ("UnitedHealth" or "the Company") (NYSE: UNH) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
If You Invested $5,000 In Vanguard High Dividend Yield VYM 10 Years Ago, This Is How Much Cash From Dividends You Would Have Today
Key Points Higher than normal volatility in the stock market has left many investors unaccustomed to wide intraday market swings reeling. The Vanguard High Dividend Yield Index Fund ETF offers a nice combination of growth, income, and diversification risk management along with lower volatility in a highly liquid ETF format. Dividend Reinvestment Plans (DRIP) can be an excellent way to build wealth through compounding, but doesn’t preclude regular portfolio monitoring. SmartAsset’s free tool can match you with a financial advisor in minutes to help you answer intimidating retirement concerns. Each advisor has been carefully trained to analyze and act in your best interests to deliver on your portfolio requirements. Don’t waste another minute – get started by clicking here.(Sponsor) The volatility of the stock market over the past three months has been a roller coaster ride that has left many with a case of nausea. The Dow Jones Industrial Average has ranged from 44,882.13 at the end of January to 40,813.57 in mid-March, plummeting lower to 37,645.59 during the first week of April, then to soar back up to 42,410 in mid-May at the time of this writing. People who lack the stomach for such rapid lows and highs often leave the market altogether or seek a less turbulent asset class, while still being able to see gains in some form or fashion. For those who find bonds too stodgy but like the idea of lower volatility with some growth and an income component, the realm of dividend stocks has long been a popular choice of institutions and retirees. 24/7 Wall Street has a sizeable database of dividend stocks and has published numerous articles on the topic that showcased different sample combinations to meet yield and sector diversity demands. For those seeking the added risk mitigation of diversification through a fund structure, Exchange Traded Funds (ETF) are an excellent way to access dividend stock benefits without single stock risks. For a solid high dividend yield ETF, one worth serious consideration is the Vanguard High Dividend Yield Index Fund ETF (NYSE: VYM). The Vanguard High Dividend Yield Index Fund ETF – Dividend Cash in a Decade Created 19 years ago in 2006, The Vanguard High Dividend Yield Index Fund ETF is Vanguard’s ETF for investors seeking to track the FTSE High Dividend Yield Index. For a quick thumbnail description of VYM as of the tie of this writing: Total Assets $70.42 billion Yield 2.97% Average Daily Volume 1.51 million shares Expense Ratio 0.06% 52 Week Range 112.05-135.10 Beta 0.82 1 year returns 10.03% 3 year returns 8.26% 5 year returns 13.25% 10 year returns 9.48% Composition of the ETF: Top 5 Largest holdings: Top 5 Largest Industrial Sectors: Broadcom 4.0% Financial Services 20.61% JP Morgan Chase 3.58% Healthcare 14.71% Exxon Mobil 2.72% Technology 12.77% UnitedHealth Group 2.51% Consumer Defensive 12.58% Procter & Gamble 2.09% Industrials 10.89% A $5,000 investment in VYM back in January, 2015 would be worth $12,552.82 today, as of the time of this writing, which equates to a cumulative 155.67% ROI. The total return would be $7,552.85. The annualized return equates to 9.64%. This calculation also includes compounding through reinvested dividends. The reinvested dividend value equates to $3,379.55. The actual cash dividends paid out from the initial 71.02 shares equates to $2,049.82. If the dividends were not reinvested, the total return would be $4,173.30. Therefore, reinvesting the dividends enabled an additional return of $3,503.73 over a 10-year long stretch. . Dividend Reinvestment Plans (DRIP) Advantages and Disadvantages Reinvesting dividends in a DRIP program can accelerate wealth building though compounding and dollar cost averaging. Dividend Reinvestment plans, as the comparison shows, can be a powerful tool for wealth building through compounding. Most DRIP arrangements do not charge additional fees, and the investments are on autopilot, so they eschew the need to place additional buy orders. Of course, entering into a DRIP arrangement assumes that the investor does not need the dividend income. Additionally, there are two other things that investors need to bear in mind with DRIP arrangement: Monitoring portfolio allocation – If a portfolio is being designed to maintain a certain ratio balance between, say 75% growth and 25% income, the ratio can get skewed if the growth portion does not add shares while the income portion continues to do so over time. Stock becomes overvalued – While buying on autopilot over the long haul may be a generally good strategy, there are times when market conditions can change to the point where a security or fund can become too expensive and overvalued. In these situations, curtailing DRIP might be prudent, and profit taking might even be a consideration in those circumstances. The post If You Invested $5,000 In Vanguard High Dividend Yield VYM 10 Years Ago, This Is How Much Cash From Dividends You Would Have Today appeared first on 24/7 Wall St..
UNH: Best Time Ever To Buy For Income Investors
UnitedHealth's shares have plunged, but the sell-off creates a rare opportunity: the dividend yield is at a historic high and the valuation is compelling. Despite near-term headwinds—guidance withdrawal, CEO change, and reported DOJ probe—I see long-term prospects as strong, with robust earnings and dividend growth expected. UNH's payout ratio is low, and dividend growth history is excellent; even conservative growth assumptions point to attractive total returns for income investors.
UNH SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that UnitedHealth Group Incorporated Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against UnitedHealth Group Incorporated ("UnitedHealth" or "the Company") (NYSE:UNH) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired UnitedHealth securities between September 22, 2021 and April 16, 2025, both dates inclusive (the "Class Period").
UNITEDHEALTH GROUP INCORPORATED (NYSE: UNH) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds UnitedHealth Group Incorporated Investors of Upcoming Deadline
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit?
UNH Investors Have Opportunity to Join UnitedHealth Group Incorporated Fraud Investigation with the Schall Law Firm
LOS ANGELES , May 19, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of UnitedHealth Group Incorporated ("UnitedHealth" or "the Company") (NYSE: UNH) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
UNH Investors Have Opportunity to Lead UnitedHealth Group Incorporated Securities Fraud Lawsuit First Filed by the Firm
NEW YORK , May 19, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of UnitedHealth Group Incorporated (NYSE: UNH) between December 3, 2024 and May 12, 2025, both dates inclusive (the "Class Period"), of the important July 7, 2025 in the securities class action first filed by the firm. So What: If you purchased UnitedHealth securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UnitedHealth Group Incorporated of Class Action Lawsuit and Upcoming Deadlines - UNH
NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
UNH STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that UnitedHealth Group Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESS Newswire / May 18, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against UnitedHealth Group Incorporated ("UnitedHealth" or "the Company") (NYSE:UNH) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired UnitedHealth securities between September 22, 2021 and April 16, 2025, both dates inclusive (the "Class Period").
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages UnitedHealth Group Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm– UNH
NEW YORK, May 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of UnitedHealth Group Incorporated (NYSE: UNH) between December 3, 2024 and May 12, 2025, both dates inclusive (the “Class Period”), of the important July 7, 2025 lead plaintiff deadline.
Why UnitedHealth Is Down 50% In A Month And What Happens Next
Trump wants to cut out the middleman, will he be able to? UNH's exposure to PBM risks is real, but is the market pricing in the worst-case scenario. I look at the legal and regulatory routes to reform, as well as financial estimates on UNH of my base case.
UnitedHealth: An Investment Worth Considering At The Right Price
UnitedHealth faces significant headwinds, but the issues are fixable. The CEO replacement is highly positive, since Stephen J. Hemsley has a proven track record and over $350M worth of shares. The aging population and higher interest rates support long-term growth.
After 30% Slide, is UNH Stock a Buy? Use the 3-Day Rule to Decide
UnitedHealth Group ( UNH ) shares have come under significant pressure, collapsing by over 30% in just a few days and now sitting more than 60% below all-time highs. The selloff followed news that the company is under criminal investigation for possible Medicare fraud.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for UNH.